Experimental models of Alzheimer's disease (AD) are critical to gaining a better
understanding of pathogenesis and to assess the potential of novel therapeutic approaches …

The production of soluble amyloid-β oligomers (AβOs) and the activation of inflammation are
two important early steps in the pathogenesis of Alzheimer's disease (AD). The central role …

The amyloid cascade hypothesis, focusing on pathological proteins aggregation, has so far
failed to uncover the root cause of Alzheimer's disease (AD), or to provide an effective …

In recent decades, research scientists, molecular biologists, and pharmacologists have
placed a strong emphasis on cutting-edge nanostructured materials technologies to …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder that is growing in
prevalence globally. It is the only major cause of death without any effective …

With the constant failure of the clinical trials continuous exploration of a therapeutic target
against Alzheimer's disease (AD) is the utmost need. Numerous studies have supported the …

Abstract Alzheimer's disease (AD), the most common form of dementia, is a progressive
neurodegenerative disease. In the past decades, numbers of promising drug candidates …

Background: India is undergoing a rapid epidemiological transition, from underweight to
overweight/obese population. Obesity is a major risk factor in type 2 diabetes and …

Background Because of high prevalence of Alzheimer's disease (AD) in low-and middle-
income countries (LMICs), there is an urgent need for inexpensive and minimally invasive …

Multitarget drug discovery is one of the hottest topics and most active fields in the search for
new molecules against Alzheimer's disease (AD). Over the last 20 years, many promising …